GI
WST icon

Gradient Investments’s West Pharmaceutical WST Stock Holding History

Gradient Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$2.82K – 1858
2023
Q4 		$2.82K Hold
8
– – ﹤0.01% 1142
2023
Q3 		$3K Buy
8
+4
+100% +$1.55K ﹤0.01% 1072
2023
Q2 		$1.53K Buy
4
+3
+300% +$1.07K ﹤0.01% 1225
2023
Q1 		$346 Hold
1
– – ﹤0.01% 1319
2022
Q4 		$235 Sell
1
-25
-96% -$5.92K ﹤0.01% 1369
2022
Q3 		$6K Buy
+26
New +$7.92K ﹤0.01% 934
2019
Q4 		– Sell
-36
Closed -$5K – 1250
2019
Q3 		$5K Buy
+36
New +$4.96K ﹤0.01% 810
2019
Q1 		– Sell
-66
Closed -$6K – 1018
2018
Q4 		$6K Buy
+66
New +$7.16K ﹤0.01% 690

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Gradient Investments's WST Position: Q1 2024 in Review

Gradient Investments sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 8 shares — an estimated $2.82K sold.

Gradient Investments first reported a position in WST in Q4 2018 and held it in 8 quarters. The position peaked at $6K in Q3 2022. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Gradient Investments reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 8 West Pharmaceutical shares in Q1 2024, an estimated $2.82K.
  • Gradient Investments first reported a position in West Pharmaceutical in Q4 2018 and held it in 8 quarters.
  • Gradient Investments's West Pharmaceutical position peaked at $6K in Q3 2022.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.